Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Malka

Showing results (91-100 of 192) with videos related to

Pageof 20
Sort By:
BMC Cancer|August 8, 2018
Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973)Diane Goéré, Jean-Pierre Pignon, Maximiliano Gelli, et al.
Bulletin Du Cancer|December 20, 2023
[Hereditary and familial forms of pancreatic adenocarcinoma: Genetic determinism, patients eligible for systematic screening, screening methods and results]Ugo Marchese, Vinciane Rebours, Alain Sauvanet, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 16, 2022
Safety of direct oral anticoagulants in patients with advanced solid tumors receiving anti-VEGF agents: a retrospective studyAlice Boileve, Laurence Albiges, Michel Ducreux, et al.
European Journal of Cancer (Oxford, England : 1990)|March 3, 2020
5-Fluorouracil-induced hyperammonaemic encephalopathy: A French national surveyAlice Boilève, Laure Thomas, Agnès Lillo-Le Louët, et al.
European Journal of Cancer (Oxford, England : 1990)|July 18, 2018
Peritoneal and extraperitoneal relapse after previous curative treatment of peritoneal metastases from colorectal cancer: What survival can we expect?Maximiliano Gelli, Janina F L Huguenin, Thierry de Baere, et al.
Journal of Hepatology|October 27, 2011
Liver/biliary injuries following chemoembolisation of endocrine tumours and hepatocellular carcinoma: lipiodol vs. drug-eluting beadsBoris Guiu, Frédéric Deschamps, Serge Aho, et al.
Cardiovascular and Interventional Radiology|May 31, 2014
Predisposing factors of liver necrosis after transcatheter arterial chemoembolization in liver metastases from neuroendocrine tumorJulien Joskin, Thierry de Baere, Anne Auperin, et al.
European Journal of Cancer (Oxford, England : 1990)|December 24, 2017
Circulating oncometabolite D-2-hydroxyglutarate enantiomer is a surrogate marker of isocitrate dehydrogenase-mutated intrahepatic cholangiocarcinomasJulia Delahousse, Loic Verlingue, Sophie Broutin, et al.
Hepatology (Baltimore, Md.)|July 28, 2023
Chemotherapy with or without selective internal radiation therapy for intrahepatic cholangiocarcinoma: Data from clinical trialsJulien Edeline, John Bridgewater, Boris Campillo-Gimenez, et al.
Neuroendocrinology|June 9, 2020
Long-Term Results after Surgical Resection of Peritoneal Metastasis from Neuroendocrine TumorsLéonor Benhaim, Matthieu Faron, Julien Hadoux, et al.
Pageof 20

Showing results (91-100 of 192) with videos related to

Sort By:
Pageof 20
BMC Cancer|August 8, 2018
Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973)Diane Goéré, Jean-Pierre Pignon, Maximiliano Gelli, et al.
Bulletin Du Cancer|December 20, 2023
[Hereditary and familial forms of pancreatic adenocarcinoma: Genetic determinism, patients eligible for systematic screening, screening methods and results]Ugo Marchese, Vinciane Rebours, Alain Sauvanet, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 16, 2022
Safety of direct oral anticoagulants in patients with advanced solid tumors receiving anti-VEGF agents: a retrospective studyAlice Boileve, Laurence Albiges, Michel Ducreux, et al.
European Journal of Cancer (Oxford, England : 1990)|March 3, 2020
5-Fluorouracil-induced hyperammonaemic encephalopathy: A French national surveyAlice Boilève, Laure Thomas, Agnès Lillo-Le Louët, et al.
European Journal of Cancer (Oxford, England : 1990)|July 18, 2018
Peritoneal and extraperitoneal relapse after previous curative treatment of peritoneal metastases from colorectal cancer: What survival can we expect?Maximiliano Gelli, Janina F L Huguenin, Thierry de Baere, et al.
Journal of Hepatology|October 27, 2011
Liver/biliary injuries following chemoembolisation of endocrine tumours and hepatocellular carcinoma: lipiodol vs. drug-eluting beadsBoris Guiu, Frédéric Deschamps, Serge Aho, et al.
Cardiovascular and Interventional Radiology|May 31, 2014
Predisposing factors of liver necrosis after transcatheter arterial chemoembolization in liver metastases from neuroendocrine tumorJulien Joskin, Thierry de Baere, Anne Auperin, et al.
European Journal of Cancer (Oxford, England : 1990)|December 24, 2017
Circulating oncometabolite D-2-hydroxyglutarate enantiomer is a surrogate marker of isocitrate dehydrogenase-mutated intrahepatic cholangiocarcinomasJulia Delahousse, Loic Verlingue, Sophie Broutin, et al.
Hepatology (Baltimore, Md.)|July 28, 2023
Chemotherapy with or without selective internal radiation therapy for intrahepatic cholangiocarcinoma: Data from clinical trialsJulien Edeline, John Bridgewater, Boris Campillo-Gimenez, et al.
Neuroendocrinology|June 9, 2020
Long-Term Results after Surgical Resection of Peritoneal Metastasis from Neuroendocrine TumorsLéonor Benhaim, Matthieu Faron, Julien Hadoux, et al.
Pageof 20